Journal of Clinical Pediatrics ›› 2022, Vol. 40 ›› Issue (9): 710-714.doi: 10.12372/jcp.2022.21e1326
• Literature Review • Previous Articles Next Articles
Reviewer: YANG Baowang1, Reviser: HONG Xiaoyang2, FENG Zhichun2
Received:
2021-09-13
Published:
2022-09-15
Online:
2022-08-26
Reviewer: YANG Baowang, Reviser: HONG Xiaoyang, FENG Zhichun. Research progress of extracorporeal membrane oxygenation combined with renal replacement therapy in children[J].Journal of Clinical Pediatrics, 2022, 40(9): 710-714.
[1] |
Gorga SM, Sahay RD, Askenazi DJ, et al. Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy: a multicenter retrospective cohort study[J]. Pediatr Nephrol, 2020, 35(5): 871-882.
doi: 10.1007/s00467-019-04468-4 |
[2] |
Combes A, Peek G, Hajage D, et al. ECMO for severe ARDS: systematic review and individual patient data meta-analysis[J]. Intensive Care Med, 2020, 46(11): 2048-2057.
doi: 10.1007/s00134-020-06248-3 pmid: 33021684 |
[3] |
Gao S, Liu G, Yan S, et al. Outcomes from adult veno-arterial extracorporeal membrane oxygenation in a cardiovascular disease center from 2009 to 2019[J]. Perfusion, 2022, 37(3): 235-241.
doi: 10.1177/0267659121993365 |
[4] |
Thongprayoon C, Cheungpasitporn W, Lertjitbanjong P, et al. Incidence and impact of acute kidney injury in patients receiving extracorporeal membrane oxygenation: a meta-analysis[J]. J Clin Med, 2019, 8(7): 981.
doi: 10.3390/jcm8070981 |
[5] |
Fleming GM, Sahay R, Zappitelli M, et al. The incidence of acute kidney injury and its effect on neonatal and pediatric extracorporeal membrane oxygenation outcomes: a multicenter report from the kidney intervention during extracorporeal membrane oxygenation study group[J]. Pediatr Crit Care Med, 2016, 17(12): 1157-1169.
doi: 10.1097/PCC.0000000000000970 |
[6] |
Schmidt M, Bailey M, Kelly J, et al. Impact of fluid balance on outcome of adult patients treated with extracorporeal membrane oxygenation[J]. Intensive Care Med, 2014, 40(9): 1256-1266.
doi: 10.1007/s00134-014-3360-2 |
[7] |
Ootaki C, Yamashita M, Ootaki Y, et al. Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system[J]. J Thorac Cardiovas Surg, 2008, 136(1): 150-158.
doi: 10.1016/j.jtcvs.2007.12.023 |
[8] |
Villa G, Katz N, Ronco C. Extracorporeal membrane oxygenation and the kidney[J]. Cardiorenal Med, 2015, 6(1): 50-60.
doi: 10.1159/000439444 |
[9] | Sasser WC, Robert SM, Askenazi DJ, et al. Peritoneal dialysis: an alternative modality of fluid removal in neonates requiring extracorporeal membrane oxygenation after cardiac surgery[J]. J Extra Corpor Technol, 2014, 46(2): 157-161. |
[10] |
Li G, Zhang L, Sun Y, et al. Co-initiation of continuous renal replacement therapy, peritoneal dialysis, and extracorporeal membrane oxygenation in neonatal life-threatening hyaline membrane disease: a case report[J]. Medicine (Baltimore), 2019, 98(4): e14194.
doi: 10.1097/MD.0000000000014194 |
[11] | Gorga SM, Lima L, Askenazi DJ, et al. Fluid balance management informs renal replacement therapy use during pediatric extracorporeal membrane oxygenation: a survey report from the kidney intervention during extracorporeal membrane oxygenation group[J]. ASAIO J, 2021, 68(3): 407-412. |
[12] |
Messmer AS, Zingg C, Müller M, et al. Fluid overload and mortality in adult critical care patients - a systematic review and meta-analysis of observational studies[J]. Crit Care Med, 2020, 48(12): 1862-1870.
doi: 10.1097/CCM.0000000000004617 pmid: 33009098 |
[13] |
Davis AL, Carcillo JA, Aneja RK, et al. The American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: executive summary[J]. Pediatr Crit Care Med, 2017, 18(9): 884-890.
doi: 10.1097/PCC.0000000000001259 |
[14] |
Selewski DT, Askenazi DJ, Bridges BC, et al. The impact of fluid overload on outcomes in children treated with extracorporeal membrane oxygenation: a multicenter retrospective cohort study[J]. Pediatr Crit Care Med, 2017, 18(12): 1126-1135.
doi: 10.1097/PCC.0000000000001349 |
[15] |
Askenazi DJ, Selewski DT, Paden ML, et al. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation[J]. Clin J Am Soc Nephrol, 2012, 7(8): 1328-1336.
doi: 10.2215/CJN.12731211 |
[16] | Lee SW, Yu MY, Lee H, et al. Risk Factors for acute kidney injury and in-hospital mortality in patients receiving extracorporeal membrane oxygenation[J]. PLoS One, 2015, 10(10): e0140674. |
[17] |
STARRT-AKI Investigators, et al. Canadian Critical Care Trials Group, Australian and New Zealand Intensive Care Society Clinical Trials Group,Timing of initiation of renal-replacement therapy in acute kidney injury[J]. N Engl J Med, 2020, 383(3): 240-251.
doi: 10.1056/NEJMoa2000741 |
[18] |
Han SS, Kim HJ, Lee SJ, et al. Effects of renal replacement therapy in patients receiving extracorporeal membrane oxygenation: a meta-analysis[J]. Ann Thorac Surg, 2015, 100(4): 1485-1495.
doi: 10.1016/j.athoracsur.2015.06.018 |
[19] |
Murphy HJ, Eklund MJ, Hill J, et al. Early continuous renal replacement therapy during infant extracorporeal life support is associated with decreased lung opacification[J]. J Artif Organs, 2019, 22(4): 286-293.
doi: 10.1007/s10047-019-01119-1 pmid: 31342287 |
[20] |
Murphy HJ, Cahill JB, Twombley KE, et al. Early continuous renal replacement therapy improves nutrition delivery in neonates during extracorporeal life support[J]. J Ren Nutr, 2018, 28(1): 64-70.
doi: 10.1053/j.jrn.2017.06.008 |
[21] |
Paek JH, Park S, Lee A, et al. Timing for initiation of sequential continuous renal replacement therapy in patients on extracorporeal membrane oxygenation[J]. Kidney Res Clin Pract, 2018, 37(3): 239-247.
doi: 10.23876/j.krcp.2018.37.3.239 |
[22] |
Joannidis M, Forni LG, Klein SJ, et al. Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup[J]. Intensive Care Med, 2020, 46(4): 654-672.
doi: 10.1007/s00134-019-05869-7 pmid: 31820034 |
[23] |
Ostermann M, Connor M Jr, Kashani K. Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how?[J]. Curr Opin Crit Care, 2018, 24(6): 493-503.
doi: 10.1097/MCC.0000000000000559 pmid: 30325343 |
[24] |
Seczyńska B, Królikowski W, Nowak I, et al. Continuous renal replacement therapy during extracorporeal membrane oxygenation in patients treated in medical intensive care unit: technical considerations[J]. Ther Apher Dial, 2014, 18(6): 523-534.
doi: 10.1111/1744-9987.12188 |
[25] |
Jenks CL, Zia A, Venkataraman R, et al. High hemoglobin is an independent risk factor for the development of hemolysis during pediatric extracorporeal life support[J]. J Intensive Care Med, 2019, 34(3): 259-264.
doi: 10.1177/0885066617708992 |
[26] |
Giani M, Scaravilli V, Stefanini F, et al. Continuous renal replacement therapy in venovenous extracorporeal membrane oxygenation: a retrospective study on regional citrate anticoagulation[J]. ASAIO J, 2020, 66(3): 332-338.
doi: 10.1097/MAT.0000000000001003 |
[27] |
Chen H, Yu RG, Yin NN, et al. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review[J]. Crit Care, 2014, 18(6): 675.
doi: 10.1186/s13054-014-0675-x |
[28] |
Meyer RJ, Brophy PD, Bunchman TE, et al. Survival and renal function in pediatric patients following extracorporeal life support with hemofiltration[J]. Pediatr Crit Care Med, 2001, 2(3): 238-242.
doi: 10.1097/00130478-200107000-00009 |
[29] |
Paden ML, Warshaw BL, Heard ML, et al. Recovery of renal function and survival after continuous renal replacement therapy during extracorporeal membrane oxygenation[J]. Pediatr Crit Care Med, 2011, 12(2): 153-158.
doi: 10.1097/PCC.0b013e3181e2a596 |
[30] |
Vinclair C, De Montmollin E, Sonneville R, et al. Factors associated with major adverse kidney events in patients who underwent veno-arterial extracorporeal membrane oxygenation[J]. Ann Intensive Care, 2020, 10(1): 44.
doi: 10.1186/s13613-020-00656-w pmid: 32307616 |
[1] | LUO Mingjing, YU Jiaming, WANG Xiaodong, ZHANG Xiaoling, YU Yue, ZHANG Yu, WEN Feiqiu, LIU Sixi. Clinical analysis of invasive fungal disease secondary to allogeneic hematopoietic stem cell transplantation in 424 children with thalassemia [J]. Journal of Clinical Pediatrics, 2025, 43(1): 21-28. |
[2] | LIU Dongxia, JIN Rong, LIN Rongjun. Risk factors analysis of severe refractory Mycoplasma pneumoniae pneumonia complicated with bronchitis obliterans in children [J]. Journal of Clinical Pediatrics, 2025, 43(1): 29-34. |
[3] | ZHONG Jinhong, WANG Can, CHEN Fang. Progress in the research of infantile fiberoptic bronchoscopy sedation [J]. Journal of Clinical Pediatrics, 2025, 43(1): 50-55. |
[4] | JIANG Weiqin, WANG Jing, CHENG Anna, CHEN Tingting, HUANG Yujuan. Predictors of recurrent febrile seizures during the same febrile illness in children with febrile seizures [J]. Journal of Clinical Pediatrics, 2025, 43(1): 8-13. |
[5] | QIU Xiu, WEI Dongmei, LIN Shanshan, XIA Huimin, ZHOU Wenhao. Principles and practice of the Born in Guangzhou Cohort Study [J]. Journal of Clinical Pediatrics, 2024, 42(9): 747-752. |
[6] | FAN Jianxia. The origins and development of the healthy life trajectory program: a cohort of community-family-mother-child multidimensional interventions for overweight and obesity in children [J]. Journal of Clinical Pediatrics, 2024, 42(9): 768-773. |
[7] | JIANG Tao, LI Shuangjie, TANG Lian, OUYANG Wenxian. Immunobiological properties of peripheral blood MAIT cells in children with chronic hepatitis B [J]. Journal of Clinical Pediatrics, 2024, 42(9): 787-790. |
[8] | ZHOU Jie, LIU Keqiang, WANG Jinling, WANG Ying. Megacystis-microcolon-intestinal hypoperistalsis syndrome caused by MYH11 elongating mutation : a case report and literatures review [J]. Journal of Clinical Pediatrics, 2024, 42(9): 798-804. |
[9] | CHU Sijia, TANG Jihong. Research progress of central nervous system injury associated with pediatric acute lymphoblastic leukemia and its treatment [J]. Journal of Clinical Pediatrics, 2024, 42(9): 811-816. |
[10] | DING Yaping, XIA Shanshan, ZHANG Chenmei. Interpretation of “2023 Children’s Renal Nutrition Working Group Clinical Practice Recommendations: Nutritional Management of Children with Acute Kidney Injury” [J]. Journal of Clinical Pediatrics, 2024, 42(8): 667-672. |
[11] | LI Yirong, LI Huiping, GAO Jingyu, XIAO Yuhua, CHEN Xiaomin, LU Yanling, ZHAO Nana, FENG Xiaoqin. Comparison of different doses of cytarabine for induction chemotherapy in children with acute myeloid leukemia in FLAG-IDA regimen [J]. Journal of Clinical Pediatrics, 2024, 42(8): 673-677. |
[12] | HUANG Bo, DONG Yanying, SONG Linlan. Clinical characteristics of 348 children with infectious mononucleosis [J]. Journal of Clinical Pediatrics, 2024, 42(8): 678-683. |
[13] | WANG Dan, SHAO Jingbo, LI Hong, ZHANG Na, ZHU Jiashi, FU Pan, WANG Zhen. Clinical analysis of 38 cases of hematological malignancies complicated with tumor lysis syndrome in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 684-690. |
[14] | MA Yan, WEI Xingjiao, BAI Hua, ZHANG Yan, TIAN Xinmin, Aqsa Ahmad, LIANG Lijun. Analysis of etiological composition and clinical features of stage 5 chronic kidney disease in children in a tertiary hospital in western China [J]. Journal of Clinical Pediatrics, 2024, 42(8): 697-703. |
[15] | WANG Ye, ZHANG Linlin, CHI Zuofei, SUN Ruowen, JIANG Zehui, XU Gang. A case of clinical report of T-lymphoblastic lymphoma secondary to acute promyelocytic leukemia in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 722-727. |
|